Endocrine Testing Market - Latest Advancements & Market Outlook 2018 to 2026

Endocrine Testing Market
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2018–2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Endocrine Testing Market Overview
The Global Endocrine Testing Market, by Test (Thyroid, Insulin, Follicle Stimulating Hormone,
Luteinizing, Hormone, Estradiol, Testosterone, Progesterone, Human chorionic gonadotropin,
Prolactin, Cortisol DHEA-S, and Others), by Diagnostic Technology (Immunoassay, Tandem Mass
Spectroscopy, Monoclonal and Polyclonal Antibody, Sensor Technologies, Clinical Chemistry, and
Others), by End User (Hospitals, Diagnostic Laboratories, and others), and by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2.95
billion in 2017 and is projected to exhibit a CAGR of 4.9% over the forecast period (2018 – 2026),
as highlighted in a new report published by Coherent Market Insights.
To get holistic SAMPLE of the report including table of contents:
https://www.coherentmarketinsights.com/insight/request-sample/1755
Endocrine testing allows profiling of blood concentration of the various endocrine hormone.
Over secretion and under secretion of endocrinal hormones results in to development of
endocrinal disease. Various endocrinal disease such as hypothyroidism, hyperthyroidism,
infertility, polycystic ovarian syndrome, hypo/hyperadrenocorticism, hypogonadism, diabetes,
Multiple endocrine neoplasia I and II, Cushing’s disease, Gigantism (acromegaly) and other
growth hormone problem and precocious puberty( Early Puberty). Endocrine diseases are
caused due to various reasons such as problem in endocrine feedback system, disease
condition, and failure of stimulation of glands to release hormones, tumor of an endocrine
gland, genetic disorders, infection and physical trauma to an endocrine gland.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Increasing prevalence of these disease especially hypothyroidism, infertility, and
diabetes are expected to drive growth of the global endocrinal testing market.
According to study published by Centre for Disease Control and Prevention (CDC), in
2017, around 100 million (30.3 million diabetes and 84.1 million prediabetes) U.S.
adults were suffering from diabetes or prediabetes condition. According to American
Thyroid Association, 2017, around 12% of U.S. adults are estimated to develop thyroid
disease in their lifetime. Postmenopausal osteoporosis caused due to reduced estrogen
production after menopause leading to low bone mineral density and increased risk for
fracture risks. It is estimated that osteoporosis affects around 10 million American
adults annually, 34 million people are at high risk of it due to low bone mass, according
to study published by BMC Endocrine Disorder in February 2018.
Browse 45 Market Data Tables and 35 Figures spread through 200 Pages and in-depth
TOC on “Endocrine Testing Market - by Test (Thyroid, Insulin, Follicle Stimulating
Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Progesterone, Human
chorionic gonadotropin, Prolactin, Cortisol DHEA-S and Others), by Diagnostic
Technology (Immunoassay, Tandem Mass Spectroscopy, Monoclonal and Polyclonal
Antibody, Sensor Technologies, Clinical Chemistry, and Others), by End User (Hospitals,
Diagnostic Laboratories and others), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa)- Global forecast to 2026”
Browse Research Report At:
https://www.coherentmarketinsights.com/market-insight/endocrine-testing-market-1755
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Key players are undergoing strategic mergers, acquisitions, and collaborations in order to
maintain leading position in market and to tap the new market. In August 2017, North West
London Pathology under National Health Service Trust and Abbott Laboratories signed contract
worth US$ 252 million under which Abbott Laboratories will supply all analytical equipment and
consumables, this contract would manage 26 million tests annually. In 2017, Abbott
Laboratories received the U.S. Food and Drug Administration (FDA) 510(k) clearance for its
Alinity ci-series instruments for clinical chemistry and immunoassay diagnostics. In April 2018,
Beckman Coulter launched its Access Sensitive Estradiol assay in the U.S. market, also made
available its assay in the most of global markets
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/1755
Increasing ageing population is also expected to aid in growth of the endocrine testing market,
owing to high prevalence of endocrinal disease. According to population Prospect report by
United Nations in 2017, an estimated 962 million people are aged 60 or above in the world,
which accounted for 13% of the global population. The number of older people in the world is
projected to be 1.4 billion growing at annual rate of 3% by 2030.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

The Global Endocrine Testing Market, by Test (Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Progesterone, Human chorionic gonadotropin, Prolactin, Cortisol DHEA-S, and Others), by Diagnostic Technology (Immunoassay, Tandem Mass Spectroscopy, Monoclonal and Polyclonal Antibody, Sensor Technologies, Clinical Chemistry, and Others), by End User (Hospitals, Diagnostic Laboratories, and others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2.95 billion in 2017 and is projected to exhibit a CAGR of 4.9% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.